U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07580027) titled 'Preoperative, Adaptive Radiotherapy Concomitant to Chemotherapy for Rectal Adenocarcinoma (Adaptive Rectal Cancer Trial 02)' on March 20.

Brief Summary: The aim of this clinical study is to increase the rate of pathological responses up to 70% by means of improved patient selection operated by a radiobiological index called ERI\_TCP and by an increase in the dose of radiotherapy in the final concomitant boost of preoperative radiochemotherapy treatment for rectal adenocarcinoma.

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Locally Advanced Rectal Carcinoma

Intervention: RADIATION: Preoperative, adaptive radi...